Virtus ETF Advisers LLC Vbi Vaccines Inc Transaction History

Virtus ETF Advisers LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.66 - $1.81 $45,685 - $125,288	-69,220 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $5,218 - $10,149	-4,109 Reduced 5.6%	69,220 $115,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $162,057 - $236,119	73,329 New	73,329 $172,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.